Natural Products for Cancer Therapeutics

Tech ID: 19544 / UC Case 2006-079-0

Technology Description

Although algorithms and chemistries for developing new therapeutic entities are constantly evolving, none can replicate the path and novelty of natural selection over eons of time. Inventors at the Scripps Institution of Oceanography have engaged their fleet of research ships to cull the oceans for marine organisms from which new compositions are isolated.  Using a variety of culture systems, selective fractionation and bioassays, two, distinct classes of compounds, isolated from actinomycetes, have demonstrated potent anti-tumor activity and considerable selectivity toward some cancers. One class of compounds, the ammosamides, are unique molecules that target a previously untargeted intracellular pathway. It is anticipated that proprietary methods and naturally evolved compositions may yield therapeutics that are significantly differentiated from those developed by limited iteration of pre-defined platforms.

Related Materials

State Of Development

Potent anticancer activity against HCT-116 (human colon cancer cells).

Intellectual Property Info

Patents pending; see WO/2009/006319.

Patent Status

Country Type Number Dated Case
United States Of America Issued Patent 8,133,902 03/13/2012 2006-079
 

Other Information

Categorized As

Related cases

2006-079-0, 2010-351-0, 2010-329-0, 2003-248-0

Keywords

chemical entity, chemical entities, composition, marine, tumor, composition

Contact

University of California, San Diego Technology Transfer Office / invent@ucsd.edu / tel: View Phone Number. Please reference Tech ID #19544.

University of California, San Diego
Technology Transfer Office

9500 Gilman Drive, MC 0910, La Jolla, CA 92093-0910 | invent.ucsd.edu
Tel: 858.534.5815 | Fax: 858.534.7345 | invent@ucsd.edu